Monaco Asset Management SAM Grows Position in Perrigo Company plc (NYSE:PRGO)

Monaco Asset Management SAM raised its holdings in shares of Perrigo Company plc (NYSE:PRGO - Free Report) by 20.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 179,095 shares of the company's stock after acquiring an additional 30,000 shares during the quarter. Perrigo makes up 0.7% of Monaco Asset Management SAM's portfolio, making the stock its 15th largest holding. Monaco Asset Management SAM owned 0.13% of Perrigo worth $4,605,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Versant Capital Management Inc purchased a new position in shares of Perrigo during the 4th quarter worth $45,000. GAMMA Investing LLC boosted its stake in shares of Perrigo by 93.7% during the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division boosted its stake in shares of Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock worth $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC purchased a new position in shares of Perrigo during the 3rd quarter worth $56,000. Finally, KBC Group NV boosted its stake in shares of Perrigo by 25.1% during the 3rd quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after acquiring an additional 905 shares during the last quarter. Hedge funds and other institutional investors own 95.91% of the company's stock.

Insider Buying and Selling at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the sale, the executive vice president now directly owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.70% of the stock is currently owned by insiders.

Remove Ads

Perrigo Price Performance

Shares of PRGO stock traded down $0.44 on Tuesday, hitting $27.83. 2,301,863 shares of the stock traded hands, compared to its average volume of 1,432,208. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of -23.78 and a beta of 0.48. Perrigo Company plc has a 52 week low of $23.14 and a 52 week high of $33.46. The firm has a 50 day simple moving average of $25.48 and a two-hundred day simple moving average of $26.16. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.92 by $0.01. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. As a group, equities research analysts predict that Perrigo Company plc will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th will be issued a $0.29 dividend. This is an increase from Perrigo's previous quarterly dividend of $0.28. This represents a $1.16 dividend on an annualized basis and a yield of 4.17%. The ex-dividend date of this dividend is Friday, March 7th. Perrigo's payout ratio is currently -92.80%.

Analysts Set New Price Targets

Several research analysts have recently weighed in on PRGO shares. Argus cut shares of Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Piper Sandler downgraded shares of Perrigo from an "overweight" rating to a "neutral" rating and decreased their price objective for the company from $34.00 to $27.00 in a research report on Monday, January 6th. Finally, StockNews.com downgraded shares of Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat, Perrigo has a consensus rating of "Hold" and an average target price of $33.00.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.